{"id":18819,"date":"2021-11-12T10:48:22","date_gmt":"2021-11-12T09:48:22","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=18819"},"modified":"2021-11-12T10:48:50","modified_gmt":"2021-11-12T09:48:50","slug":"la-unidad-de-innovacion-y-desarrollo-de-negocio-del-idibell-participa-en-el-mayor-congreso-de-industrias-biotecnologicas-de-europa","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2021\/11\/la-unidad-de-innovacion-y-desarrollo-de-negocio-del-idibell-participa-en-el-mayor-congreso-de-industrias-biotecnologicas-de-europa\/","title":{"rendered":"La Unidad de Innovaci\u00f3n y Desarrollo de Negocio del IDIBELL participa en el mayor congreso de industrias biotecnol\u00f3gicas de Europa"},"content":{"rendered":"<p>El \u00c1rea de Innovaci\u00f3n y Desarrollo de Negocio del IDIBELL ha asistido al encuentro <strong>BIO-Europe Digital 2021<\/strong>. Este es el evento m\u00e1s importante de la industria biotecnol\u00f3gica, farmac\u00e9utica y financiera especializada en las ciencias de la vida en el \u00e1mbito europeo. El BIO-Europe atrae a un amplio abanico de l\u00edderes empresariales, incluyendo ejecutivos l\u00edderes de compa\u00f1\u00edas biotecnol\u00f3gicas, equipos de desarrollo de negocio, inversores y otros expertos de la industria.<\/p>\n<p>Durante el congreso, que se celebr\u00f3 del 25 al 28 de octubre, los representantes del IDIBELL asistieron a un total de<strong> 63 reuniones con 43 farmac\u00e9uticas, 8 compa\u00f1\u00edas de capital riesgo, 6 delegados y 6 expertos cient\u00edficos<\/strong>. \u00ab<em>Esperamos aprovechar el impulso que acabamos de crear durante BIO-Europa para seguir colaborando y creciendo durante el 2022<\/em>\u00ab, concluyen desde el \u00c1rea de Innovaci\u00f3n y desarrollo de negocio.<\/p>\n<p>Generar acuerdos y conectar con compa\u00f1eros y compa\u00f1eras del sector sigue siendo una parte relevante de la creaci\u00f3n de proyectos de \u00e9xito. Seg\u00fan los organizadores, esta edici\u00f3n del BIO-Europe fueron 4 d\u00edas intensos con la participaci\u00f3n de 2.941 delegados de 1.686 empresas representantes de 55 pa\u00edses que participaron en m\u00e1s de 15.000 reuniones.<\/p>\n<p>En 2022 BIO-Europe ser\u00e1 en formato presencial y tendr\u00e1 lugar Leipzig, Alemania, en los pr\u00f3ximos 24-26 de octubre. \u00c9sta ser\u00e1 la primera sesi\u00f3n presencial desde 2019.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L&#8217;Hospitalet de Llobregat.<\/em><\/p>\n<p><em>El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa \u00abHR Excellence in Research\u00bb de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Este es el evento m\u00e1s importante de la industria biotecnol\u00f3gica, farmac\u00e9utica y financiera especializada en las ciencias de la vida en el \u00e1mbito europeo.<\/p>\n","protected":false},"author":8,"featured_media":18820,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[374],"tags":[],"class_list":["post-18819","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innovacion"],"publishpress_future_action":{"enabled":false,"date":"2025-01-02 21:16:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/18819","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=18819"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/18819\/revisions"}],"predecessor-version":[{"id":18821,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/18819\/revisions\/18821"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/18820"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=18819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=18819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=18819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}